It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Stryker Corporation: "I think Stryker is very, very interesting here. The medical device group is good, but I do prefer Edwards Lifesciences Corp more than Stryker."
Johnson & Johnson: "Johnson & Johnson is good and going higher. I have to tell you my charitable trust sold it too soon because we decided that we wanted to have a little more extra with Allergan, but JNJ is OK."
Merck & Co: "You've got JNJ and you've got Merck. I've got to tell you that I think Merck lags JNJ. They don't have that extra growth that I like to see. I would never tell anybody to sell Merck, but I don't like the product profile as much as JNJ."
Unilever: "Boy I like Unilever! The management is really on top of things. They've got the emerging market going really, really well. I think that stock can go up 10 percent. By the way, the strong dollar? It's good for them."
Goldman Sachs: "Goldman Sachs, are you kidding me? I love it! The book value is $176 and that's ridiculous. I think it goes to $210."
China Mobile: "No. The communist party takes too much control over stocks there. After this most recent downturn, I am not recommending any Chinese stocks."
Dyax Corporation: "Oh man, that is just a tough one. It's too speculative for me. It's good for a young person. But way too speculative for most of my people."
GW Pharmaceuticals: "Another one that has been a little too speculative. I've got to tell you, this is one that I got behind very early on. This is marijuana unfortunately for people/kids with epilepsy. But I think the stock is now too speculative given that this is a very tough market for a Celgene or even for a Gilead."
Read more from Mad Money with Jim Cramer
Abiomed: "You know that stock got hammered, and I thought was ridiculous how hard it got hammered! I think it represents great value. That was insane that it went down so much."
Northrop Grumman Corporation: "I think it's absolutely terrific. Northrop Grumman is in a foot race with Lockheed Martin to go higher. NOC won that big bomber contract and I thought it would go to LMT. I like LMT a little more right now at $214, but Northrop is good."
Baidu Inc: "No, I can't. I know that is one that I would love to recommend. But because of this most recent downturn — and they have U.S.-like financials — I do not trust Baidu. I have to be a very tough guy on these Chinese stocks after what happened this summer."